Concepts (347)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognition | 49 | 2023 | 1314 | 8.210 |
Why?
|
| Brain | 40 | 2023 | 1727 | 5.050 |
Why?
|
| White Matter | 11 | 2022 | 150 | 4.820 |
Why?
|
| Aging | 36 | 2023 | 1630 | 4.710 |
Why?
|
| Cognitive Dysfunction | 32 | 2023 | 969 | 4.270 |
Why?
|
| Aged | 118 | 2023 | 9620 | 3.890 |
Why?
|
| Alzheimer Disease | 30 | 2023 | 2005 | 3.740 |
Why?
|
| Neuropsychological Tests | 61 | 2023 | 1270 | 3.650 |
Why?
|
| Cardiovascular Diseases | 13 | 2023 | 411 | 3.360 |
Why?
|
| Magnetic Resonance Imaging | 38 | 2023 | 1247 | 2.980 |
Why?
|
| Cognition Disorders | 19 | 2020 | 1032 | 2.910 |
Why?
|
| Diffusion Tensor Imaging | 12 | 2023 | 84 | 2.820 |
Why?
|
| Humans | 147 | 2023 | 29855 | 2.690 |
Why?
|
| Female | 103 | 2023 | 16429 | 2.620 |
Why?
|
| Male | 100 | 2023 | 15870 | 2.580 |
Why?
|
| Hypertension | 7 | 2022 | 272 | 2.410 |
Why?
|
| Depression | 8 | 2020 | 472 | 2.300 |
Why?
|
| Executive Function | 21 | 2023 | 124 | 2.250 |
Why?
|
| Middle Aged | 72 | 2023 | 9962 | 2.160 |
Why?
|
| Blood Pressure | 8 | 2022 | 251 | 2.040 |
Why?
|
| Aged, 80 and over | 55 | 2023 | 4930 | 1.990 |
Why?
|
| Dementia | 16 | 2023 | 527 | 1.900 |
Why?
|
| Verbal Learning | 11 | 2021 | 43 | 1.890 |
Why?
|
| Diet, Mediterranean | 5 | 2023 | 64 | 1.860 |
Why?
|
| Memory Disorders | 7 | 2018 | 177 | 1.820 |
Why?
|
| Acculturation | 3 | 2023 | 35 | 1.810 |
Why?
|
| Memory, Short-Term | 11 | 2023 | 103 | 1.770 |
Why?
|
| Connectome | 5 | 2021 | 14 | 1.770 |
Why?
|
| Risk Factors | 26 | 2023 | 2467 | 1.660 |
Why?
|
| Gray Matter | 5 | 2023 | 56 | 1.620 |
Why?
|
| Prefrontal Cortex | 7 | 2016 | 153 | 1.590 |
Why?
|
| Neuroimaging | 10 | 2023 | 138 | 1.540 |
Why?
|
| Health Literacy | 3 | 2023 | 105 | 1.500 |
Why?
|
| Cerebrovascular Disorders | 4 | 2021 | 139 | 1.430 |
Why?
|
| Residence Characteristics | 4 | 2021 | 216 | 1.370 |
Why?
|
| Decision Making | 6 | 2023 | 227 | 1.320 |
Why?
|
| Arteriolosclerosis | 3 | 2023 | 74 | 1.230 |
Why?
|
| Public Health | 6 | 2021 | 62 | 1.230 |
Why?
|
| Brain Mapping | 10 | 2021 | 199 | 1.200 |
Why?
|
| Mental Status and Dementia Tests | 4 | 2021 | 81 | 1.120 |
Why?
|
| United States | 18 | 2021 | 2346 | 1.090 |
Why?
|
| Cohort Studies | 19 | 2023 | 1953 | 1.080 |
Why?
|
| Depressive Disorder | 5 | 2017 | 192 | 1.080 |
Why?
|
| Nerve Fibers, Myelinated | 5 | 2013 | 40 | 1.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2018 | 194 | 1.050 |
Why?
|
| Depressive Disorder, Major | 9 | 2018 | 108 | 1.050 |
Why?
|
| Tryptophan | 5 | 2014 | 15 | 1.050 |
Why?
|
| Memory | 10 | 2021 | 323 | 1.030 |
Why?
|
| Apolipoproteins E | 4 | 2023 | 235 | 1.030 |
Why?
|
| Cognitive Aging | 3 | 2020 | 81 | 0.980 |
Why?
|
| Exercise | 7 | 2022 | 474 | 0.970 |
Why?
|
| Cross-Sectional Studies | 14 | 2023 | 970 | 0.970 |
Why?
|
| Stroke | 5 | 2023 | 294 | 0.970 |
Why?
|
| Hippocampus | 9 | 2022 | 285 | 0.950 |
Why?
|
| Educational Status | 5 | 2023 | 297 | 0.940 |
Why?
|
| Psychomotor Performance | 9 | 2020 | 220 | 0.930 |
Why?
|
| Pattern Recognition, Visual | 2 | 2019 | 31 | 0.920 |
Why?
|
| Diabetes Mellitus | 3 | 2020 | 140 | 0.900 |
Why?
|
| Linear Models | 6 | 2020 | 258 | 0.890 |
Why?
|
| Spatial Processing | 2 | 2021 | 6 | 0.890 |
Why?
|
| Income | 3 | 2021 | 77 | 0.860 |
Why?
|
| Mental Recall | 7 | 2020 | 74 | 0.850 |
Why?
|
| Adult | 28 | 2023 | 8748 | 0.840 |
Why?
|
| Social Participation | 1 | 2022 | 11 | 0.830 |
Why?
|
| Genotype | 5 | 2020 | 409 | 0.830 |
Why?
|
| Crime Victims | 1 | 2022 | 25 | 0.820 |
Why?
|
| Leukoaraiosis | 3 | 2012 | 6 | 0.820 |
Why?
|
| Blood Glucose | 2 | 2022 | 112 | 0.800 |
Why?
|
| Clinical Protocols | 1 | 2022 | 64 | 0.790 |
Why?
|
| Analysis of Variance | 10 | 2017 | 327 | 0.790 |
Why?
|
| Anisotropy | 5 | 2023 | 60 | 0.790 |
Why?
|
| Optimism | 1 | 2021 | 1 | 0.760 |
Why?
|
| Psychology | 1 | 2021 | 21 | 0.750 |
Why?
|
| Family Relations | 1 | 2021 | 10 | 0.750 |
Why?
|
| Longitudinal Studies | 13 | 2023 | 1462 | 0.750 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2018 | 201 | 0.740 |
Why?
|
| Cerebral Cortex | 4 | 2021 | 197 | 0.730 |
Why?
|
| Social Segregation | 1 | 2020 | 8 | 0.730 |
Why?
|
| Social Environment | 1 | 2021 | 81 | 0.730 |
Why?
|
| Dementia, Vascular | 5 | 2020 | 44 | 0.720 |
Why?
|
| Racism | 1 | 2021 | 32 | 0.720 |
Why?
|
| Loneliness | 1 | 2021 | 55 | 0.720 |
Why?
|
| Antihypertensive Agents | 2 | 2020 | 85 | 0.710 |
Why?
|
| Cholesterol | 2 | 2019 | 54 | 0.710 |
Why?
|
| Social Capital | 1 | 2020 | 4 | 0.710 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 97 | 0.710 |
Why?
|
| Triglycerides | 1 | 2019 | 45 | 0.680 |
Why?
|
| Social Support | 1 | 2021 | 186 | 0.680 |
Why?
|
| Dyslipidemias | 1 | 2019 | 23 | 0.670 |
Why?
|
| Glomerular Filtration Rate | 1 | 2019 | 59 | 0.670 |
Why?
|
| Hyperinsulinism | 1 | 2019 | 4 | 0.660 |
Why?
|
| Life Style | 1 | 2021 | 212 | 0.660 |
Why?
|
| Mental Processes | 1 | 2019 | 18 | 0.660 |
Why?
|
| Cultural Diversity | 1 | 2019 | 24 | 0.650 |
Why?
|
| Multilingualism | 1 | 2019 | 11 | 0.650 |
Why?
|
| Community Health Services | 1 | 2019 | 31 | 0.640 |
Why?
|
| Prospective Studies | 13 | 2022 | 1823 | 0.640 |
Why?
|
| Insulin Resistance | 1 | 2019 | 61 | 0.640 |
Why?
|
| Independent Living | 6 | 2022 | 285 | 0.640 |
Why?
|
| Neural Pathways | 9 | 2018 | 83 | 0.630 |
Why?
|
| Stress, Psychological | 1 | 2021 | 249 | 0.630 |
Why?
|
| Phenotype | 2 | 2019 | 364 | 0.620 |
Why?
|
| Kidney | 1 | 2019 | 176 | 0.610 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2023 | 221 | 0.600 |
Why?
|
| Psychological Trauma | 1 | 2017 | 3 | 0.590 |
Why?
|
| Affect | 3 | 2013 | 65 | 0.560 |
Why?
|
| Wounds and Injuries | 1 | 2017 | 44 | 0.560 |
Why?
|
| Serotonin | 4 | 2014 | 43 | 0.550 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 447 | 0.540 |
Why?
|
| Individuality | 1 | 2016 | 22 | 0.540 |
Why?
|
| Metabolic Diseases | 1 | 2015 | 14 | 0.490 |
Why?
|
| Psychomotor Disorders | 1 | 2014 | 10 | 0.490 |
Why?
|
| Thinking | 1 | 2014 | 15 | 0.490 |
Why?
|
| Verbal Behavior | 5 | 2009 | 20 | 0.480 |
Why?
|
| Obesity | 4 | 2023 | 290 | 0.480 |
Why?
|
| Sex Factors | 6 | 2020 | 498 | 0.460 |
Why?
|
| Age Factors | 8 | 2020 | 854 | 0.460 |
Why?
|
| Surveys and Questionnaires | 10 | 2021 | 1186 | 0.460 |
Why?
|
| Frontal Lobe | 5 | 2018 | 85 | 0.450 |
Why?
|
| Vascular Diseases | 2 | 2013 | 53 | 0.440 |
Why?
|
| Alleles | 5 | 2023 | 226 | 0.440 |
Why?
|
| Memory, Episodic | 3 | 2018 | 120 | 0.440 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2012 | 35 | 0.430 |
Why?
|
| Health Surveys | 4 | 2021 | 96 | 0.420 |
Why?
|
| Models, Statistical | 3 | 2021 | 133 | 0.410 |
Why?
|
| Attention | 6 | 2023 | 145 | 0.410 |
Why?
|
| Galvanic Skin Response | 1 | 2011 | 10 | 0.400 |
Why?
|
| Gambling | 1 | 2011 | 8 | 0.400 |
Why?
|
| Dancing | 2 | 2021 | 7 | 0.390 |
Why?
|
| Case-Control Studies | 9 | 2023 | 643 | 0.390 |
Why?
|
| Models, Psychological | 1 | 2011 | 67 | 0.390 |
Why?
|
| Down Syndrome | 1 | 2011 | 10 | 0.380 |
Why?
|
| Brain Chemistry | 1 | 2011 | 46 | 0.380 |
Why?
|
| Crime | 2 | 2021 | 9 | 0.370 |
Why?
|
| Biomarkers | 4 | 2021 | 704 | 0.370 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2023 | 181 | 0.360 |
Why?
|
| Basal Ganglia Cerebrovascular Disease | 1 | 2010 | 1 | 0.350 |
Why?
|
| Chicago | 3 | 2021 | 867 | 0.350 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2016 | 222 | 0.350 |
Why?
|
| Sex Characteristics | 2 | 2022 | 135 | 0.340 |
Why?
|
| Reaction Time | 6 | 2023 | 124 | 0.340 |
Why?
|
| Neural Inhibition | 2 | 2014 | 10 | 0.330 |
Why?
|
| Apolipoprotein E4 | 3 | 2020 | 233 | 0.320 |
Why?
|
| Psychiatric Status Rating Scales | 7 | 2017 | 351 | 0.310 |
Why?
|
| Myelin Sheath | 2 | 2021 | 18 | 0.300 |
Why?
|
| Amnesia | 5 | 2020 | 27 | 0.290 |
Why?
|
| Self Report | 3 | 2023 | 221 | 0.290 |
Why?
|
| Learning | 2 | 2018 | 80 | 0.280 |
Why?
|
| Principal Component Analysis | 3 | 2021 | 26 | 0.280 |
Why?
|
| Young Adult | 7 | 2021 | 1969 | 0.270 |
Why?
|
| Language | 3 | 2021 | 78 | 0.270 |
Why?
|
| Visual Perception | 2 | 2020 | 50 | 0.270 |
Why?
|
| Hospitalization | 2 | 2019 | 319 | 0.270 |
Why?
|
| Pilot Projects | 3 | 2022 | 403 | 0.270 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 803 | 0.270 |
Why?
|
| Prevalence | 4 | 2021 | 494 | 0.270 |
Why?
|
| Nerve Net | 5 | 2018 | 54 | 0.270 |
Why?
|
| DNA-Binding Proteins | 3 | 2023 | 263 | 0.260 |
Why?
|
| Problem Solving | 2 | 2009 | 47 | 0.250 |
Why?
|
| Discrimination Learning | 1 | 2004 | 3 | 0.240 |
Why?
|
| Color Perception | 1 | 2004 | 6 | 0.240 |
Why?
|
| Models, Neurological | 3 | 2018 | 32 | 0.230 |
Why?
|
| Arousal | 1 | 2004 | 44 | 0.230 |
Why?
|
| Temporal Lobe | 3 | 2018 | 109 | 0.230 |
Why?
|
| Autistic Disorder | 2 | 2014 | 46 | 0.220 |
Why?
|
| Severity of Illness Index | 5 | 2017 | 1126 | 0.220 |
Why?
|
| Postmenopause | 1 | 2023 | 61 | 0.220 |
Why?
|
| Intelligence Tests | 2 | 2015 | 15 | 0.210 |
Why?
|
| Time Factors | 2 | 2019 | 1641 | 0.210 |
Why?
|
| Adolescent | 6 | 2021 | 2334 | 0.210 |
Why?
|
| Research Design | 2 | 2021 | 214 | 0.210 |
Why?
|
| Fraud | 1 | 2022 | 23 | 0.210 |
Why?
|
| Psychometrics | 2 | 2021 | 264 | 0.200 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 558 | 0.200 |
Why?
|
| Atherosclerosis | 1 | 2023 | 75 | 0.200 |
Why?
|
| Socioeconomic Factors | 2 | 2021 | 329 | 0.200 |
Why?
|
| Awareness | 1 | 2002 | 38 | 0.200 |
Why?
|
| Geriatric Assessment | 3 | 2017 | 221 | 0.200 |
Why?
|
| Regression Analysis | 5 | 2018 | 299 | 0.200 |
Why?
|
| Facial Expression | 2 | 2012 | 16 | 0.200 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2023 | 118 | 0.190 |
Why?
|
| Data Interpretation, Statistical | 3 | 2022 | 98 | 0.190 |
Why?
|
| Social Identification | 1 | 2021 | 5 | 0.190 |
Why?
|
| Social Networking | 1 | 2021 | 10 | 0.190 |
Why?
|
| Cerebral Small Vessel Diseases | 1 | 2021 | 12 | 0.190 |
Why?
|
| Accelerometry | 2 | 2021 | 87 | 0.190 |
Why?
|
| Genome-Wide Association Study | 2 | 2020 | 304 | 0.190 |
Why?
|
| Emotions | 2 | 2012 | 90 | 0.180 |
Why?
|
| Treatment Outcome | 2 | 2022 | 3561 | 0.180 |
Why?
|
| Southeastern United States | 1 | 2020 | 9 | 0.180 |
Why?
|
| Midwestern United States | 1 | 2020 | 67 | 0.180 |
Why?
|
| Organ Size | 3 | 2023 | 107 | 0.180 |
Why?
|
| Wechsler Scales | 3 | 2006 | 15 | 0.180 |
Why?
|
| Mental Status Schedule | 3 | 2011 | 114 | 0.180 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 349 | 0.180 |
Why?
|
| Space Perception | 1 | 2020 | 28 | 0.170 |
Why?
|
| Judgment | 1 | 2019 | 9 | 0.170 |
Why?
|
| Acute Disease | 2 | 2012 | 225 | 0.170 |
Why?
|
| Cholesterol, HDL | 1 | 2019 | 30 | 0.170 |
Why?
|
| Cholesterol, LDL | 1 | 2019 | 33 | 0.170 |
Why?
|
| Disabled Persons | 1 | 2021 | 129 | 0.170 |
Why?
|
| HIV Infections | 2 | 2021 | 997 | 0.170 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 332 | 0.170 |
Why?
|
| Patient Selection | 1 | 2021 | 234 | 0.170 |
Why?
|
| Interpersonal Relations | 1 | 2020 | 105 | 0.170 |
Why?
|
| Hypercholesterolemia | 1 | 2019 | 29 | 0.170 |
Why?
|
| Pandemics | 1 | 2021 | 237 | 0.160 |
Why?
|
| Atrophy | 2 | 2016 | 106 | 0.160 |
Why?
|
| Follow-Up Studies | 6 | 2019 | 1859 | 0.160 |
Why?
|
| Financing, Personal | 1 | 2018 | 19 | 0.160 |
Why?
|
| Emergencies | 1 | 2019 | 39 | 0.160 |
Why?
|
| Energy Intake | 1 | 2019 | 66 | 0.160 |
Why?
|
| Cognitive Reserve | 1 | 2019 | 38 | 0.160 |
Why?
|
| Genetic Variation | 1 | 2018 | 110 | 0.160 |
Why?
|
| Heterozygote | 1 | 2018 | 103 | 0.150 |
Why?
|
| Double-Blind Method | 3 | 2014 | 522 | 0.150 |
Why?
|
| Healthy Lifestyle | 1 | 2017 | 28 | 0.140 |
Why?
|
| Healthy Aging | 1 | 2017 | 13 | 0.140 |
Why?
|
| Phobia, Social | 1 | 2016 | 12 | 0.140 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2016 | 23 | 0.140 |
Why?
|
| Motor Skills | 1 | 2017 | 62 | 0.140 |
Why?
|
| Neurodegenerative Diseases | 1 | 2018 | 117 | 0.140 |
Why?
|
| Self-Assessment | 2 | 2020 | 29 | 0.140 |
Why?
|
| Predictive Value of Tests | 2 | 2011 | 532 | 0.140 |
Why?
|
| Gyrus Cinguli | 2 | 2016 | 22 | 0.130 |
Why?
|
| Prognosis | 1 | 2019 | 874 | 0.130 |
Why?
|
| Anxiety Disorders | 1 | 2017 | 169 | 0.130 |
Why?
|
| Urban Population | 1 | 2017 | 143 | 0.130 |
Why?
|
| Bipolar Disorder | 1 | 2016 | 128 | 0.130 |
Why?
|
| Cytokines | 1 | 2017 | 350 | 0.120 |
Why?
|
| Cerebrovascular Circulation | 2 | 2014 | 44 | 0.120 |
Why?
|
| Macromolecular Substances | 1 | 2014 | 17 | 0.120 |
Why?
|
| Parkinson Disease | 2 | 2020 | 1184 | 0.120 |
Why?
|
| Inflammation | 3 | 2023 | 347 | 0.120 |
Why?
|
| Statistics as Topic | 1 | 2014 | 114 | 0.120 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2016 | 190 | 0.120 |
Why?
|
| Axons | 1 | 2013 | 38 | 0.110 |
Why?
|
| Animals | 2 | 2013 | 4640 | 0.110 |
Why?
|
| Visual Cortex | 1 | 2012 | 8 | 0.100 |
Why?
|
| Auditory Cortex | 1 | 2012 | 4 | 0.100 |
Why?
|
| Oxygen | 1 | 2012 | 86 | 0.100 |
Why?
|
| Language Tests | 2 | 2021 | 29 | 0.100 |
Why?
|
| Photic Stimulation | 3 | 2020 | 45 | 0.100 |
Why?
|
| Reward | 1 | 2011 | 34 | 0.100 |
Why?
|
| Task Performance and Analysis | 1 | 2011 | 55 | 0.100 |
Why?
|
| Social Class | 2 | 2022 | 65 | 0.100 |
Why?
|
| Inositol | 1 | 2011 | 7 | 0.100 |
Why?
|
| Aspartic Acid | 1 | 2011 | 15 | 0.100 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 44 | 0.100 |
Why?
|
| Genes, MHC Class I | 1 | 2010 | 4 | 0.090 |
Why?
|
| HLA-B Antigens | 1 | 2010 | 10 | 0.090 |
Why?
|
| Antigen Presentation | 1 | 2010 | 21 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 744 | 0.090 |
Why?
|
| Weight Loss | 2 | 2023 | 101 | 0.090 |
Why?
|
| Syndrome | 1 | 2010 | 88 | 0.090 |
Why?
|
| Pain Measurement | 1 | 2011 | 468 | 0.080 |
Why?
|
| Medicare | 2 | 2019 | 123 | 0.080 |
Why?
|
| Neuropathology | 2 | 2019 | 81 | 0.080 |
Why?
|
| Cues | 2 | 2011 | 61 | 0.080 |
Why?
|
| Comorbidity | 1 | 2009 | 504 | 0.080 |
Why?
|
| Cluster Analysis | 2 | 2011 | 53 | 0.070 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 55 | 0.070 |
Why?
|
| Lewy Bodies | 2 | 2019 | 198 | 0.070 |
Why?
|
| Functional Laterality | 1 | 2007 | 94 | 0.070 |
Why?
|
| HIV-1 | 1 | 2010 | 451 | 0.070 |
Why?
|
| Reading | 1 | 2006 | 40 | 0.070 |
Why?
|
| Dominance, Cerebral | 1 | 2004 | 23 | 0.060 |
Why?
|
| Evoked Potentials | 1 | 2004 | 19 | 0.060 |
Why?
|
| Limbic System | 1 | 2004 | 11 | 0.060 |
Why?
|
| Disease Progression | 2 | 2021 | 812 | 0.060 |
Why?
|
| Cross-Over Studies | 2 | 2014 | 80 | 0.060 |
Why?
|
| Reproduction | 1 | 2023 | 12 | 0.060 |
Why?
|
| Estrogens | 1 | 2023 | 37 | 0.050 |
Why?
|
| Baltimore | 1 | 2003 | 14 | 0.050 |
Why?
|
| Sample Size | 1 | 2003 | 25 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2023 | 57 | 0.050 |
Why?
|
| Age of Onset | 2 | 2013 | 110 | 0.050 |
Why?
|
| Infarction | 1 | 2023 | 25 | 0.050 |
Why?
|
| Social Determinants of Health | 1 | 2023 | 28 | 0.050 |
Why?
|
| Reference Values | 1 | 2003 | 231 | 0.050 |
Why?
|
| Maze Learning | 1 | 2002 | 17 | 0.050 |
Why?
|
| Boston | 1 | 2022 | 28 | 0.050 |
Why?
|
| Cholinergic Antagonists | 1 | 2022 | 13 | 0.050 |
Why?
|
| Physical Therapy Modalities | 1 | 2022 | 81 | 0.050 |
Why?
|
| Pregnancy | 1 | 2023 | 388 | 0.050 |
Why?
|
| Psychotic Disorders | 1 | 2002 | 45 | 0.050 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 22 | 0.050 |
Why?
|
| Incidental Findings | 1 | 2021 | 16 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 156 | 0.050 |
Why?
|
| Probability | 1 | 2021 | 94 | 0.050 |
Why?
|
| Factor Analysis, Statistical | 1 | 2021 | 78 | 0.050 |
Why?
|
| Caribbean Region | 1 | 2020 | 4 | 0.050 |
Why?
|
| South America | 1 | 2020 | 4 | 0.050 |
Why?
|
| Information Dissemination | 1 | 2021 | 22 | 0.050 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2020 | 3 | 0.050 |
Why?
|
| Amino Acids | 2 | 2010 | 21 | 0.050 |
Why?
|
| Lung | 1 | 2021 | 158 | 0.050 |
Why?
|
| New York | 1 | 2020 | 10 | 0.040 |
Why?
|
| Florida | 1 | 2020 | 21 | 0.040 |
Why?
|
| California | 1 | 2020 | 31 | 0.040 |
Why?
|
| Orientation | 1 | 2020 | 10 | 0.040 |
Why?
|
| Walking | 1 | 2022 | 254 | 0.040 |
Why?
|
| Puerto Rico | 1 | 2019 | 12 | 0.040 |
Why?
|
| Cerebral Ventricles | 1 | 2019 | 23 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 2020 | 64 | 0.040 |
Why?
|
| Primary Prevention | 1 | 2019 | 39 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 399 | 0.040 |
Why?
|
| Amyloid | 1 | 2018 | 54 | 0.040 |
Why?
|
| Lewy Body Disease | 1 | 2019 | 100 | 0.040 |
Why?
|
| Serial Learning | 1 | 2018 | 8 | 0.040 |
Why?
|
| Amygdala | 1 | 2018 | 50 | 0.040 |
Why?
|
| Health Status | 1 | 2019 | 230 | 0.040 |
Why?
|
| Perception | 1 | 2018 | 83 | 0.040 |
Why?
|
| Comoros | 1 | 2017 | 1 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2019 | 150 | 0.040 |
Why?
|
| Caloric Restriction | 1 | 2017 | 11 | 0.040 |
Why?
|
| Neurofibrillary Tangles | 1 | 2018 | 189 | 0.040 |
Why?
|
| tau Proteins | 1 | 2018 | 213 | 0.040 |
Why?
|
| Sphygmomanometers | 1 | 2017 | 3 | 0.040 |
Why?
|
| Autopsy | 1 | 2018 | 338 | 0.040 |
Why?
|
| Massachusetts | 1 | 2017 | 19 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2017 | 56 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2017 | 109 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 223 | 0.030 |
Why?
|
| Czech Republic | 1 | 2014 | 1 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2014 | 29 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2017 | 425 | 0.030 |
Why?
|
| Thalamus | 1 | 2014 | 28 | 0.030 |
Why?
|
| Semantics | 1 | 2014 | 20 | 0.030 |
Why?
|
| Corpus Striatum | 1 | 2014 | 113 | 0.030 |
Why?
|
| Sensation | 1 | 2012 | 17 | 0.030 |
Why?
|
| HLA-A Antigens | 1 | 2010 | 12 | 0.020 |
Why?
|
| HLA-C Antigens | 1 | 2010 | 9 | 0.020 |
Why?
|
| HIV Long-Term Survivors | 1 | 2010 | 10 | 0.020 |
Why?
|
| HIV Antigens | 1 | 2010 | 22 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2010 | 70 | 0.020 |
Why?
|
| Haplotypes | 1 | 2010 | 61 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2010 | 82 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2011 | 91 | 0.020 |
Why?
|
| Viral Load | 1 | 2010 | 208 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2010 | 91 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 410 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 307 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2010 | 174 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2009 | 327 | 0.020 |
Why?
|
| Age Distribution | 1 | 2007 | 95 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2011 | 3325 | 0.010 |
Why?
|